Ergoteles’s Envoy Medical COCH Stock Holding History

Ergoteles’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-26,400	Closed	-$267K	–	1337
2022 Q4	$267K	Hold	26,400	–	–	0.01%	958
2022 Q3	$260K	Buy	+26,400	New	+$259K	0.01%	1052

Other funds holding COCH

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Ergoteles's COCH Position: Q1 2023 in Review

Ergoteles sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 26,400 shares — an estimated $267K sold.

Ergoteles first reported a position in COCH in Q3 2022 and held it in 2 quarters. The position peaked at $267K in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

Ergoteles reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 26,400 Envoy Medical shares in Q1 2023, an estimated $267K.
Ergoteles first reported a position in Envoy Medical in Q3 2022 and held it in 2 quarters.
Ergoteles's Envoy Medical position peaked at $267K in Q4 2022.
24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.